Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 4/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | NOS1 | P29475 | 5/20 | 0.50 |
| ▸ | HRH4 | Q9H3N8 | 4/20 | 0.50 |
| ▸ | NOS3 | P29474 | 3/20 | 0.50 |
| ▸ | NOS2 | P35228 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.45 |
| ▸ | HRH2 | P25021 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | APP | P05067 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | APEX1 | P27695 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22834187 | 0.98 | CYP1A2 (0.50) | CYP1A2CYP2C19LMNANOS1HRH4 | |
| SCHEMBL5070049 | 0.86 | LMNA (0.61) | CYP1A2CYP2C19LMNANOS1HRH4 | |
| SCHEMBL20598830 | 0.79 | LMNA (0.48) | CYP1A2CYP2C19LMNANOS1HRH4 | |
| SCHEMBL5317979 | 0.78 | APP (0.44) | CYP1A2CYP2C19LMNAAPPBLM | |
| SCHEMBL7831490 | 0.78 | APP (0.39) | CYP2C19LMNANOS1NOS3NOS2 | |
| SCHEMBL6819541 | 0.75 | APP (0.41) | CYP2C19LMNAALDH1A1MAPTAPP | |
| Guanidine SCHEMBL11566422 | 0.74 | APP (0.44) | CYP2C19LMNAALDH1A1MAPTAPP | |
| Sulfuric Acid SCHEMBL11528486 | 0.74 | NOS1 (0.67) | CYP1A2CYP2C19LMNANOS1HRH4 | |
| Bromide SCHEMBL8582620 | 0.73 | HRH4 (0.77) | CYP1A2CYP2C19LMNANOS1HRH4 | |
| SCHEMBL9193111 | 0.73 | CYP1A2 (0.71) | CYP1A2CYP2C19LMNANOS1HRH4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 360 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4381120-A1 | COMPOSITIONS AND METHODS FOR THE ELECTRODEPOSITION OF NANOTWINNED COPPER | MacDermid Enthone Inc. (US) | 2024-06-12 | — | — | EP | claimed |
| WO-2023014524-A1 | COMPOSITIONS AND METHODS FOR THE ELECTRODEPOSITION OF NANOTWINNED COPPER | MACDERMID ENTHONE INC. (US) | 2023-02-09 | — | — | WO | claimed |
| CN-109863261-B | Defect-free filling method of through silicon via and copper plating solution used for filling method | 韩国生产技术研究院 | 2021-08-20 | — | — | CN | claimed |
| US-20200330931-A1 | FUNCTIONALIZED SILICON NANOMEMBRANES AND USES THEREOF | SIMPORE INC. | 2020-10-22 | — | — | US | claimed |
| CN-107635676-B | Pretreatment method for electroless plating | 麦克德米德股份有限公司 | 2020-09-18 | — | — | CN | claimed |
| CN-106011802-B | Electroless nickel plating bath and electroless nickel plating method using the same | 上村工业株式会社 | 2019-12-13 | — | — | CN | claimed |
| WO-2019136398-A1 | FUNCTIONALIZED SILICON NANOMEMBRANES AND USES THEREOF | SIMPORE INC. (US) | 2019-07-11 | — | — | WO | claimed |
| US-20180355499-A1 | MANUFACTURING METHOD OF ULTRA-LARGE COPPER GRAINS WITHOUT HEAT TREATMENT | LHTECH CO., LTD. (TW) | 2018-12-13 | — | — | US | claimed |
| US-10006135-B2 | Electroplating bath and method for producing dark chromium layers | Atotech Deutschland LLP (US) | 2018-06-26 | — | — | US | claimed |
| EP-3297772-A1 | METHOD OF PRETREATMENT FOR ELECTROLESS PLATING | MacDermid, Incorporated (US) | 2018-03-28 | — | — | EP | claimed |
| US-20040074778-A1 | Plating bath and method for depositing a metal layer on a substrate | SHIPLEY COMPANY, L.L.C. (US) | 2004-04-22 | — | — | US | claimed |
| US-20030102226-A1 | Plating bath and method for depositing a metal layer on a substrate | SHIPLEY COMPANY, L.L.C. | 2003-06-05 | — | — | US | claimed |
| US-20030085132-A1 | Plating bath and method for depositing a metal layer on a substrate | SHIPLEY COMPANY, L.L.C. | 2003-05-08 | — | — | US | claimed |
| EP-1308541-A1 | Plating bath and method for depositing a metal layer on a substrate | Shipley Company LLC (US) | 2003-05-07 | — | — | EP | claimed |
| US-20030066756-A1 | Plating bath and method for depositing a metal layer on a substrate | SHIPLEY COMPANY, L.L.C. | 2003-04-10 | — | — | US | claimed |
| EP-1300486-A1 | Plating bath and method for depositing a metal layer on a substrate | Shipley Co. L.L.C. (US) | 2003-04-09 | — | — | EP | claimed |
| EP-1300487-A1 | Plating bath and method for depositing a metal layer on a substrate | Shipley Co. L.L.C. (US) | 2003-04-09 | — | — | EP | claimed |
| EP-1300488-A2 | Plating path and method for depositing a metal layer on a substrate | Shipley Co. L.L.C. (US) | 2003-04-09 | — | — | EP | claimed |
| EP-1029329-A1 | CONDUCTIVE POLYMER COMPOSITIONS | Corning Communications Limited (GB) | 2000-08-23 | — | — | EP | claimed |
| WO-1999024991-A1 | CONDUCTIVE POLYMER COMPOSITIONS | CORNING COMMUNICATIONS LIMITED (GB) | 1999-05-20 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200330931-A1 | FUNCTIONALIZED SILICON NANOMEMBRANES AND USES THEREOF | EPCAM, SELE, L1CAM | CYP1A2 4452/4885CYP2C19 4634/4885LMNA 1763/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.